Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Remedy Robotics has developed the world’s first remotely operable endovascular robot. The company completed its first-in-human clinical procedures in Toronto in November–December 2024, demonstrating fully robotic catheter placement and withdrawal. Early results indicate successful remote operation and potential to expand access to life-saving interventions for stroke and cardiovascular emergencies. Further clinical trials are planned to support widespread deployment of the system.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Remedy Robotics.